Correlation Between Encore Capital and Silo Pharma
Can any of the company-specific risk be diversified away by investing in both Encore Capital and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Encore Capital and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Encore Capital Group and Silo Pharma, you can compare the effects of market volatilities on Encore Capital and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Encore Capital with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Encore Capital and Silo Pharma.
Diversification Opportunities for Encore Capital and Silo Pharma
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Encore and Silo is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Encore Capital Group and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Encore Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Encore Capital Group are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Encore Capital i.e., Encore Capital and Silo Pharma go up and down completely randomly.
Pair Corralation between Encore Capital and Silo Pharma
Given the investment horizon of 90 days Encore Capital is expected to generate 4.96 times less return on investment than Silo Pharma. But when comparing it to its historical volatility, Encore Capital Group is 4.61 times less risky than Silo Pharma. It trades about 0.02 of its potential returns per unit of risk. Silo Pharma is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 149.00 in Silo Pharma on September 3, 2024 and sell it today you would lose (49.00) from holding Silo Pharma or give up 32.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Encore Capital Group vs. Silo Pharma
Performance |
| Timeline |
| Encore Capital Group |
| Silo Pharma |
Encore Capital and Silo Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Encore Capital and Silo Pharma
The main advantage of trading using opposite Encore Capital and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Encore Capital position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.| Encore Capital vs. Guild Holdings Co | Encore Capital vs. Mr Cooper Group | Encore Capital vs. CNFinance Holdings | Encore Capital vs. Security National Financial |
| Silo Pharma vs. Protagenic Therapeutics | Silo Pharma vs. Rezolute | Silo Pharma vs. Lumos Pharma | Silo Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |